TG Therapeutics | TGTX - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
AbbVie USD 740M 40M 2025-06
Alaunos Therapeutics USD 1.07M 215K 2023-06
Amgen USD 653M 32M 2025-12
Ardelyx USD 5.76M 37K 2025-12
Arrowhead Research USD 22.5M 811K 2025-12
Bayer EUR 675M 87M 2025-12
Biogen USD 72.6M 12.6M 2025-06
Corcept Therapeutics USD 823.61M 21.88M 2025-09
Curis USD 178K 441K 2023-12
Gilead Sciences USD 255M 1000K 2025-12
Infinity Pharmaceuticals USD 45K 0 2023-06
J&J USD 18M 290M 2025-09
Karyopharm Therapeutics USD 11.38M 2.43M 2024-09
Novartis USD 304M 23M 2025-12
Novavax USD 5.82M 342K 2025-12
PTC Therapeutics USD 50.58M 2.59B 2025-12
Puma Biotechnology USD 3.37M 11K 2024-06
Regeneron Pharmaceuticals USD 12.2M 7.1M 2025-12
Roche Holding CHF 304M 7.5M 2025-06
TG Therapeutics USD 6.53M 187K 2025-12
Verastem USD 1.15M 10K 2024-09
Vertex Pharmaceuticals USD 3.3M 0 2025-12